Company: SVREW
Filing Date: 2025-01-31
Form Type: 424B5
Source: 0001213900-25-008656
Chunk: 13

Company: SaverOne 2014 Ltd.
Filing Date: 2025-01-31
Form: 424B5
Chunk 13
---
aid in cash or with the proceeds of an Advance under the SEPA. Recent Development Regarding Nasdaq Compliance On May 17, 2024, we received notification from the Nasdaq Staff that the closing bid price for our ADSs was below $1.00 per ADS for the previous 31 consecutive business days, and that the Company no longer meets the Minimum Bid Requirement under the Rule. The Nasdaq Staff granted the Company a new compliance period of 180 calendar days, or until November 13, 2024, to regain compliance with the Minimum Bid Price Requirement. On October 28, 2024, the Company effected the Reverse Stock Split. To regain compliance with the Rule, the Company’s ADSs needed to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive business days. On November 12, 2024, the Company received notice from Nasdaq that for the 10 consecutive business days, from October 28 to November 11, 2024, the closing bid price of the Company’s ADSs has been at $1.00 ADS or greater and that the Company has regained compliance with the Minimum Bid Price Rule, and this matter is now closed. Corporate Information We were incorporated in Israel on November 16, 2014. Our principal executive office is located at Em Hamoshavot Rd. 94, Petah Tikvah, Israel and our phone number is +972-3909-4177. We maintain a corporate website at https://saver.one. Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus. We have included our website address in this prospectus solely as an inactive textual reference. The information contained on, or that can be accessed through, our website is neither a part of nor incorporated into this prospectus. We have included our website address in this prospectus solely as an inactive textual reference. We have duly designated Puglisi & Associates, with offices at 850 Library Avenue, Newark, Delaware 1971, as our authorized agent in the United States in connection with this offering. Summary of Risks Our business is subject to numerous risks and uncertainties, including those highlighted in the section titled “Risk Factors” below and other risk factors contained in the documents incorporated by reference hereinbefore deciding whether to invest in our securities. These risks include, among others, the following: Risks Related to Our Financial Condition and Capital Requirements

| ● | We are an early